Figure 4
(A) change from baseline to endpoint in on time of CDS vs Placebo in PD patients with motor complications; (B) change from baseline to endpoint in off time reduction of CDS vs Placebo in PD patients with motor complications.
Figure 4 | Scientific Reports
